跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIDIMAZ 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TIDIMAZ 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION
Approved
STANDARD
TIDIMAZ 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION
Brill Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 19, 2022
Approval ID
e72753a6c9d24a71
Company
Brill Pharma S.L.
Type
Standard
Approval Details
Approval Id
e72753a6c9d24a71
Drug Cima Aemps Name
TIDIMAZ 20 MG/ML + 5 MG/ML COLIRIO EN SOLUCION
Register Number
86765
Holder Company Name
Brill Pharma S.L.
Marketing Company Name
Brill Pharma S.L.
Authorization Date
2022-07-19
Dosage Form
COLIRIO EN SOLUCIÓN
Dose
20 mg/ml + 5 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Brill Pharma S.L.
Active Ingredients
DORZOLAMIDA HIDROCLORURO
22,26 mg/ml
TIMOLOL MALEATO
6,83 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 19, 2022
Approval ID
e72753a6c9d24a71
Type
Standard
Back to CIMA-AEMPS Approvals
